|
Index of reports
> Cases with Foetal Distress Syndrome ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Levemir (Insulin Detemir Subcutaneous) where reactions include foetal distress syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Levemir side effects in 37 year old female
Reported by a physician from South Africa on 2012-08-20
Patient: 37 year old female, weighing 80.0 kg (176.0 pounds)
Reactions: Foetal Distress Syndrome, Maternal Exposure During Pregnancy
Drug(s) suspected as cause:
Levemir
Dosage: 8 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
End date: 2012-01-25
Novorapid Flexpen
Dosage: 18 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
End date: 2012-01-25
Possible Levemir side effects in 37 year old female
Reported by a physician from South Africa on 2012-08-06
Patient: 37 year old female, weighing 80.0 kg (176.0 pounds)
Reactions: Foetal Distress Syndrome, Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Levemir
Dosage: 8 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
End date: 2012-01-25
Novorapid Flexpen
Dosage: 18 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
End date: 2012-01-25
Possible Levemir side effects in 37 year old female
Reported by a physician from South Africa on 2012-07-27
Patient: 37 year old female, weighing 80.0 kg (176.0 pounds)
Reactions: Foetal Distress Syndrome, Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Levemir
Dosage: 8 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
End date: 2012-01-25
Novorapid Flexpen
Dosage: 18 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
End date: 2012-01-25
Other drugs received by patient: Adalat
Possible Levemir side effects in 37 year old female
Reported by a physician from South Africa on 2012-07-16
Patient: 37 year old female, weighing 80.0 kg (176.0 pounds)
Reactions: Foetal Distress Syndrome, Caesarean Section, Maternal Exposure During Pregnancy
Drug(s) suspected as cause:
Levemir
Dosage: 8 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
Novorapid Flexpen
Dosage: 18 u, qd
Indication: Gestational Diabetes
Start date: 2012-01-04
Other drugs received by patient: Adalat
|
